Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28350| Title: | Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273]. | Austin Authors: | Reck, M;Ciuleanu, T-E;Cobo, M;Schenker, M;Zurawski, B;Menezes, J;Richardet, E;Bennouna, J;Felip, E;Juan-Vidal, O;Alexandru, A;Sakai, H;Lingua, A;Reyes, F;Souquet, P-J;De Marchi, P;Martin, C;Pérol, M;Scherpereel, A;Lu, S;Paz-Ares, L;Carbone, D P;Memaj, A;Marimuthu, S;Zhang, X;Tran, P;John, Thomas | Affiliation: | Medical Oncology Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany. Electronic address: m.reck@lungenclinic.de Department of Oncology, Institutul Oncologic Prof Dr Ion Chiricuta and UMF Iuliu Hatieganu, Cluj-Napoca, Romania Department of Medical Oncology, Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain Department of Oncology, SF Nectarie Oncology Center, Craiova, Romania Department of Clinical Oncology, Ambulatorium Chemioterapii, Bydgoszcz, Poland Department of Oncology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil Department of Clinical Oncology, Instituto Oncológico de Córdoba, Córdoba, Argentina Department of Thoracic Oncology, University Hospital of Nantes and INSERM, CRCINA, Nantes, France Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain Department of Oncology, Institute of Oncology Prof Dr Alexandru Trestioreanu Bucha, Bucharest, Romania Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan Department of Medical Oncology, Instituto Medico Rio Cuarto, SA, Córdoba, Argentina Department of Medical Oncology, Fundación Arturo López Pérez, Santiago, Metropolitana, Chile Department of Pneumology, Hôpital Lyon Sud, Lyon, Pierre Bénite, France Department of Oncology, Barretos Cancer Hospital, Barretos, Brazil Department of Thoracic Oncology, Instituto Alexander Fleming, Buenos Aires, Argentina Department of Thoracic Oncology, Léon Bérard Cancer Center, Lyon, France Department of Pulmonary and Thoracic Oncology, University of Lille, CHU Lille, INSERM U1189, OncoThAI, Lille, France Department of Medical Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, China Department of Medical Oncology, Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Clinical Research Unit, Universidad Complutense & CiberOnc, Madrid, Spain Department of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA Bristol Myers Squibb, Princeton, USA |
Issue Date: | 2-Dec-2021 | Date: | 2021-12-02 | Publication information: | ESMO Open 2021; 6(6): 100345 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/28350 | DOI: | 10.1016/j.esmoop.2021.100345 | Journal: | ESMO Open | PubMed URL: | 34864501 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.